永安药业: 关于股票交易异常波动暨风险提示公告

Core Viewpoint - The stock price of Yong'an Pharmaceutical has experienced significant fluctuations, with a cumulative closing price increase exceeding 20% over two consecutive trading days, prompting the company to issue a notice regarding abnormal stock trading [1][2][3]. Group 1: Stock Trading Abnormalities - The company's stock price showed a cumulative closing price increase of over 20% on May 21 and May 22, 2025, which is classified as abnormal trading behavior according to Shenzhen Stock Exchange regulations [1][2]. - The company has been continuously releasing announcements regarding the abnormal trading fluctuations, urging investors to be cautious and make rational decisions [2][3]. Group 2: Company Verification and Situation - The board of directors conducted a verification process and confirmed that there were no significant changes in the company's fundamentals or any undisclosed major information that could impact stock prices [2][3]. - The company has not identified any recent media reports that could have significantly influenced its stock trading prices, and its operational conditions remain normal without major changes in the internal or external business environment [2][3]. Group 3: Disclosure Compliance - The board confirmed that there are no undisclosed matters that should be reported according to the Shenzhen Stock Exchange listing rules, and previous disclosures do not require corrections or supplements [3]. - The company emphasizes that all information should be based on disclosures made in designated media outlets, and it will adhere strictly to legal and regulatory requirements for information disclosure [3].